Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk: a Multi-centers, Randomized Controlled Open-label Trial

NCT07010588 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07010588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk: a Multi-centers, Randomized Controlled Open-label Trial
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
June 30, 2030
Enrollment
1,389 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc), magnetic resonance imaging (mri), randomized controlled trial